Suppr超能文献

大鼠肾细胞溶质体外对六氯-1,3-丁二烯的巯基尿酸进行脱乙酰化及进一步代谢作用

Deacetylation and further metabolism of the mercapturic acid of hexachloro-1,3-butadiene by rat kidney cytosol in vitro.

作者信息

Pratt I S, Lock E A

机构信息

Department of Pharmacology, University College, Dublin, Belfield.

出版信息

Arch Toxicol. 1988;62(5):341-5. doi: 10.1007/BF00293620.

Abstract

Hexachloro-1,3-butadiene (HCBD) is more nephrotoxic to female than male rats. Metabolism of HCBD involves conjugation with glutathione followed by formation of the cysteine conjugate S-(pentachloro-1,3-butadienyl) cysteine (PCBD-CYS) and then the mercapturic acid N-acetyl-S-pentachloro-1,3-butadienyl-cysteine (PCBD-NAC). PCBD-NAC is also more nephrotoxic to female rats than male rats. The deacetylation of [14C]-PCBD-NAC to PCBD-CYS and the binding of radiolabelled metabolites to protein has been studied using renal cytosol preparations from male and female rats in vitro, since a sex-related difference in these reactions could explain the difference in nephrotoxicity found in vivo. PCBD-NAC was rapidly metabolised by renal cytosol. The rate of metabolism was similar with either male or female renal cytosol, and the major metabolite identified was PCBD-CYS. N-Acetylation of PCBD-CYS to PCBD-NAC was not detected in the presence of either male or female renal cytosol. Covalent binding of radioactivity from [14C]-PCBD-NAC to cytosolic protein could be detected after 5 min incubation, and although the extent of binding was similar for both male and female cytosol at early time periods, after 60 min incubation more binding was found in the presence of male cytosol. Covalent binding was largely prevented by aminooxyacetic acid, an inhibitor of cysteine conjugate beta-lyase, suggesting a role for this enzyme in the activation of HCBD. These results indicate that the sex differences in the nephrotoxicity of HCBD and PCBD-NAC in the rat are not attributable to differences in the rate of deacetylation of PCBD-NAC to give the proximate nephrotoxin PCBD-CYS.

摘要

六氯-1,3-丁二烯(HCBD)对雌性大鼠的肾毒性比雄性大鼠更强。HCBD的代谢过程包括与谷胱甘肽结合,随后形成半胱氨酸共轭物S-(五氯-1,3-丁二烯基)半胱氨酸(PCBD-CYS),然后生成硫醚氨酸N-乙酰-S-五氯-1,3-丁二烯基-半胱氨酸(PCBD-NAC)。PCBD-NAC对雌性大鼠的肾毒性也比雄性大鼠更强。利用雄性和雌性大鼠的肾细胞溶质制剂在体外研究了[14C]-PCBD-NAC脱乙酰化为PCBD-CYS以及放射性标记代谢物与蛋白质的结合情况,因为这些反应中与性别相关的差异可能解释了体内发现的肾毒性差异。PCBD-NAC被肾细胞溶质迅速代谢。雄性或雌性肾细胞溶质的代谢速率相似,鉴定出的主要代谢物是PCBD-CYS。在存在雄性或雌性肾细胞溶质的情况下均未检测到PCBD-CYS乙酰化为PCBD-NAC。[14C]-PCBD-NAC的放射性与细胞溶质蛋白的共价结合在孵育5分钟后即可检测到,尽管在早期阶段雄性和雌性细胞溶质的结合程度相似,但孵育60分钟后,在存在雄性细胞溶质的情况下发现了更多的结合。半胱氨酸共轭β-裂解酶抑制剂氨氧基乙酸在很大程度上阻止了共价结合,表明该酶在HCBD的活化中起作用。这些结果表明,大鼠中HCBD和PCBD-NAC肾毒性的性别差异并非归因于PCBD-NAC脱乙酰化生成近端肾毒素PCBD-CYS的速率差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验